Sunday, August 16, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesHugel Posts Record H1 on Toxin Surge—Overseas Growth AcceleratestodayMarketHugel Posts Record H1 Revenue on Overseas Toxin Surge3 days agoDevices & TechApyx: GLP-1 Boom Is Fueling Renuvion DemandtodayMarketMedytox Q2 Sales Up 11%, Operating Profit Down 25%3 days agoInjectablesGalderma Wins EU Nod for Restylane ShaypeyesterdayBusiness & M&AEstablishment Labs Raises 2026 Revenue Guidance2 days agoDevices & TechMerz Ultherapy PRIME Clears FDA for Knee Skin LaxityyesterdayBusiness & M&ABeauty Health Q2 Earnings: Device Demand Steady2 days agoInjectablesHugel Debuts Thechaum Signature with Reduced CrosslinkeryesterdayDevices & TechAlma Launches TitaniumLift™ Multi-Depth RF Protocol2 days agoInjectablesGLP-1 Boom Exposed Filler Limitations—Here's WhyyesterdayInjectablesGalderma Chief: Start GLP-1 Patients on Skin Care First2 days ago
Markets & Filings

8-K

The SEC filing companies must file within days to disclose material events markets need to know now.

Also known as: Current Report, Form 8-K

What it is
An 8-K is a report public companies file with the SEC to disclose material events like acquisitions, executive changes, contract wins, or bankruptcies. It is generally due within four business days of the triggering event. It is the fastest formal channel for material news.
What it does
8-Ks surface tradeable events, contract awards, guidance changes, leadership shakeups, ahead of the next earnings call. Investors monitor EDGAR filings in real time for catalysts. The specific item number signals the type of event.
The evidence
Material 8-Ks disclosing major contract wins or CEO departures routinely move the filer's stock the same day.
Best for
Any single name; especially event-driven and gov-contract stocks.
Pairs well with
form-4, 13f, catalyst
Use cautiously with
Not every 8-K is material to price; boilerplate items get overweighted by inexperienced readers.
Cautions
Language can be intentionally vague, so the market's read may shift as details emerge.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

More markets & filings

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo →